A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.

Clinical trial NCT01510561 · WITHDRAWN

Trial details

NCT number: NCT01510561
Sponsor: Gilead Sciences
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2012-03-01
Primary completion: 2015-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.